These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 20300195)
1. A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene. Chatagnon A; Ballestar E; Esteller M; Dante R PLoS One; 2010 Mar; 5(3):e9665. PubMed ID: 20300195 [TBL] [Abstract][Full Text] [Related]
2. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells. Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene. Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669 [TBL] [Abstract][Full Text] [Related]
4. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins. Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729 [TBL] [Abstract][Full Text] [Related]
5. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein. Martin V; Ribieras S; Rio MC; Dante R Biol Chem; 1998; 379(4-5):409-16. PubMed ID: 9628331 [TBL] [Abstract][Full Text] [Related]
6. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
8. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. Martin V; Ribieras S; Song-Wang XG; Lasne Y; Frappart L; Rio MC; Dante R J Cell Biochem; 1997 Apr; 65(1):95-106. PubMed ID: 9138084 [TBL] [Abstract][Full Text] [Related]
9. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692 [TBL] [Abstract][Full Text] [Related]
10. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. Wagner S; Weber S; Kleinschmidt MA; Nagata K; Bauer UM J Biol Chem; 2006 Sep; 281(37):27242-50. PubMed ID: 16861234 [TBL] [Abstract][Full Text] [Related]
11. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells. Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471 [TBL] [Abstract][Full Text] [Related]
13. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863 [TBL] [Abstract][Full Text] [Related]
14. Ectopic Methylation of a Single Persistently Unmethylated CpG in the Promoter of the Vitellogenin Gene Abolishes Its Inducibility by Estrogen through Attenuation of Upstream Stimulating Factor Binding. Kallenberger L; Erb R; Kralickova L; Patrignani A; Stöckli E; Jiricny J Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31548262 [TBL] [Abstract][Full Text] [Related]
15. pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element. Barkhem T; Haldosén LA; Gustafsson JA; Nilsson S Mol Pharmacol; 2002 Jun; 61(6):1273-83. PubMed ID: 12021387 [TBL] [Abstract][Full Text] [Related]
16. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758 [TBL] [Abstract][Full Text] [Related]
17. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing. Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600 [TBL] [Abstract][Full Text] [Related]
18. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells. John Mary DJS; Sikarwar G; Kumar A; Limaye AM Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189 [TBL] [Abstract][Full Text] [Related]
19. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. Auriol E; Billard LM; Magdinier F; Dante R Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033 [TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer. Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]